← Back to Clinical Trials
Recruiting NCT07141108

NCT07141108 Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07141108
Status Recruiting
Phase
Sponsor Lund University
Condition Persistent Pain
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-05-14
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Paindrainer Care system

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-05-14 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic pain impacts individuals, their families, and society significantly, yet specialist care resources are limited, with most patients managed in primary care. There is a need for tools that support self-management and improve resource allocation. This feasibility study evaluates the implementation of Paindrainer®, a CE-marked Class I digital tool, in primary care. Paindrainer® combines patient self-monitoring via an app with a healthcare provider portal (CARE) for remote monitoring. Using advanced neural networks, it offers personalized feedback to help patients plan and monitor daily activities and their impact on pain. The study aims to assess whether integrating this tool can enhance chronic pain management and patient quality of life.

Eligibility Criteria

Inclusion Criteria: Has pain that affects daily life and has lasted for more than 3 months Is over 18 years old Understands Swedish or English Is motivated and willing to use a digital tool for self-monitoring of activity level and symptoms Has no planned surgeries during the study period Has knowledge of and access to using a smartphone or tablet Exclusion Criteria: Severe or acute mental illness, severe anxiety, or depression Ongoing history of substance use disorder Serious illness under active treatment Pain related to malignancy Currently involved in legal proceedings or ongoing litigation related to low back or neck pain \-

Contact & Investigator

Central Contact

Patrik Midlöv, Professor MD

✉ patrik.midlov@med.lu.se

📞 +46040391363

Principal Investigator

Patrik Midlöv, Professor MD

PRINCIPAL INVESTIGATOR

Lunds Universitet

Frequently Asked Questions

Who can join the NCT07141108 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Persistent Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07141108 currently recruiting?

Yes, NCT07141108 is actively recruiting participants. Contact the research team at patrik.midlov@med.lu.se for enrollment information.

Where is the NCT07141108 trial being conducted?

This trial is being conducted at Malmö, Sweden.

Who is sponsoring the NCT07141108 clinical trial?

NCT07141108 is sponsored by Lund University. The principal investigator is Patrik Midlöv, Professor MD at Lunds Universitet. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology